Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Poli

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
British Journal of Anaesthesia|November 30, 2006
Predictive performance of 'Servin's formula' during BIS-guided propofol-remifentanil target-controlled infusion in morbidly obese patientsA Albertin, D Poli, L La Colla, et al.
Thrombosis and Haemostasis|September 28, 2011
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA)V Pengo, L Crippa, A Falanga, et al.
Journal of Thrombosis and Haemostasis : JTH|March 14, 2018
Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulantsS Testa, O Paoletti, C Legnani, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2016
Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform studyS Testa, C Legnani, A Tripodi, et al.
International Journal of Laboratory Hematology|January 10, 2018
Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory RegisterM Cini, C Legnani, B Cosmi, et al.
Journal of Thrombosis and Haemostasis : JTH|February 10, 2015
Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient dataM Marcucci, A Iorio, J D Douketis, et al.
Journal of Medical Ethics|October 2, 2008
Impact of recent legislative bills regarding clinical research on Italian ethics committee activityL Porcu, D Poli, V Torri, et al.
Journal of Thrombosis and Haemostasis : JTH|April 8, 2015
Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort studyN Riva, W Ageno, D Poli, et al.
Thrombosis Research|May 11, 2016
OC-15 - Risk factors for cancer development after idiopathic venous thromboembolismB Cosmi, C Legnani, A Ghirarduzzi, et al.
Environmental Research|July 18, 2015
Urinary biomarkers of exposure and of oxidative damage in children exposed to low airborne concentrations of benzeneR Andreoli, G Spatari, D Pigini, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
British Journal of Anaesthesia|November 30, 2006
Predictive performance of 'Servin's formula' during BIS-guided propofol-remifentanil target-controlled infusion in morbidly obese patientsA Albertin, D Poli, L La Colla, et al.
Thrombosis and Haemostasis|September 28, 2011
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA)V Pengo, L Crippa, A Falanga, et al.
Journal of Thrombosis and Haemostasis : JTH|March 14, 2018
Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulantsS Testa, O Paoletti, C Legnani, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2016
Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform studyS Testa, C Legnani, A Tripodi, et al.
International Journal of Laboratory Hematology|January 10, 2018
Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory RegisterM Cini, C Legnani, B Cosmi, et al.
Journal of Thrombosis and Haemostasis : JTH|February 10, 2015
Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient dataM Marcucci, A Iorio, J D Douketis, et al.
Journal of Medical Ethics|October 2, 2008
Impact of recent legislative bills regarding clinical research on Italian ethics committee activityL Porcu, D Poli, V Torri, et al.
Journal of Thrombosis and Haemostasis : JTH|April 8, 2015
Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort studyN Riva, W Ageno, D Poli, et al.
Thrombosis Research|May 11, 2016
OC-15 - Risk factors for cancer development after idiopathic venous thromboembolismB Cosmi, C Legnani, A Ghirarduzzi, et al.
Environmental Research|July 18, 2015
Urinary biomarkers of exposure and of oxidative damage in children exposed to low airborne concentrations of benzeneR Andreoli, G Spatari, D Pigini, et al.
Pageof 7